SCHEMBL1471245

SCHEMBL1471245

FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)OC1(F)F

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6744722 1.00 LMNA (0.33) LMNA
SCHEMBL9776465 1.00 LMNA (0.33) LMNA
SCHEMBL2830039 1.00 LMNA (0.33) LMNA
SCHEMBL9770136 1.00 LMNA (0.33) LMNA
SCHEMBL29242570 1.00 LMNA (0.33) LMNA
SCHEMBL1444058 0.97
SCHEMBL1463111 0.89
SCHEMBL30087564 0.89
SCHEMBL30087579 0.89
SCHEMBL30087576 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115805087-B Catalyst system, method for the production and use thereof 上海华谊三爱富新材料有限公司 2024-02-09 CN claimed
CN-116239997-A Novel environment-friendly heat transfer fluid and preparation method thereof 纯钧新材料(深圳)有限公司 2023-06-09 CN claimed
US-20240246925-A1 MANUFACTURING METHOD OF 1,4-DIOXANE DERIVATIVE, 1,4-DIOXANE DERIVATIVE, COMPOSITION CONTAINING 1,4-DIOXANE DERIVATIVE, AND MANUFACTURING METHOD OF (1,3-DIOXOLANE)-2- CARBOXYLIC ACID DERIVATIVE, (1,3-DIOXOLANE)-2-CARBOXYLIC ACID DERIVATIVE, AND COMPOSITION CONTAINING (1,3-DIOXOLANE)-2-CARBOXYLIC ACID DERIVATIVE TOSOH CORPORATION (JP) 2024-07-25 US disclosed
EP-4342886-A1 METHOD FOR PRODUCING 1,4-DIOXANE DERIVATIVE, 1,4-DIOXANE DERIVATIVE, AND COMPOSITION CONTAINING 1,4-DIOXANE DERIVATIVE, METHOD FOR PRODUCING (1,3-DIOXOLANE)-2-CARBOXYLIC ACID DERIVATIVE, (1,3-DIOXOLANE)-2-CARBOXYLIC ACID DERIVATIVE, AND COMPOSITION CONTAINING (1,3-DIOXOLANE)-2-CARBOXYLIC ACID DERIVATIVE Tosoh Corporation (JP) 2024-03-27 EP disclosed
US-11710854-B2 Functional epoxides in catalyst-based electrolyte compositions for Li-ion batteries ENEVATE CORPORATION (US) 2023-07-25 US disclosed
US-11710854-B2 Functional epoxides in catalyst-based electrolyte compositions for Li-ion batteries ENEVATE CORPORATION (US) 2023-07-25 US disclosed
CN-116239997-A Novel environment-friendly heat transfer fluid and preparation method thereof 纯钧新材料(深圳)有限公司 2023-06-09 CN disclosed
CN-115805087-A Catalyst system, method for the production and use thereof 上海华谊三爱富新材料有限公司 2023-03-17 CN disclosed
WO-2022244715-A1 METHOD FOR PRODUCING 1,4-DIOXANE DERIVATIVE, 1,4-DIOXANE DERIVATIVE, AND COMPOSITION CONTAINING 1,4-DIOXANE DERIVATIVE, METHOD FOR PRODUCING (1,3-DIOXOLANE)-2-CARBOXYLIC ACID DERIVATIVE, (1,3-DIOXOLANE)-2-CARBOXYLIC ACID DERIVATIVE, AND COMPOSITION CONTAINING (1,3-DIOXOLANE)-2-CARBOXYLIC ACID DERIVATIVE 東ソ-株式会社 2022-11-24 WO disclosed
US-20220140392-A1 FUNCTIONAL EPOXIDES IN CATALYST-BASED ELECTROLYTE COMPOSITIONS FOR LI-ION BATTERIES ENEVATE CORPORATION 2022-05-05 US disclosed
US-9138398-B2 Cationic alcohols and uses thereof LIVING PROOF, INC. (US) 2015-09-22 US disclosed
US-20130156719-A1 CATIONIC ALCOHOLS AND USES THEREOF LIVING PROOF, INC. (US) 2013-06-20 US disclosed
US-8404221-B2 Cationic alcohols and uses thereof LIVING PROOF, INC. (US) 2013-03-26 US disclosed
US-20120276036-A1 CATIONIC ALCOHOLS AND USES THEREOF LIVING PROOF, INC. (US) 2012-11-01 US disclosed
US-8242309-B2 Cationic alcohols and uses thereof LIVING PROOF, INC. (US) 2012-08-14 US disclosed
US-20110070179-A1 CATIONIC ALCOHOLS AND USES THEREOF LIVING PROOF, INC. (US) 2011-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246925-A1 MANUFACTURING METHOD OF 1,4-DIOXANE DERIVATIVE, 1,4-DIOXANE DERIVATIVE, COMPOSITION CONTAINING 1,4-DIOXANE DERIVATIVE, AND MANUFACTURING METHOD OF (1,3-DIOXOLANE)-2- CARBOXYLIC ACID DERIVATIVE, (1,3-DIOXOLANE)-2-CARBOXYLIC ACID DERIVATIVE, AND COMPOSITION CONTAINING (1,3-DIOXOLANE)-2-CARBOXYLIC ACID DERIVATIVE ADRA1D, FDFT1, CYP1B1 LMNA 3089/4885
US-20130156719-A1 CATIONIC ALCOHOLS AND USES THEREOF ADH1A, ADH1C, TRPV1 LMNA 1620/4885
US-20120276036-A1 CATIONIC ALCOHOLS AND USES THEREOF ADH1A, ADH1C, TRPV1 LMNA 1620/4885
US-20110070179-A1 CATIONIC ALCOHOLS AND USES THEREOF ADH1A, ADH1C, TRPV1 LMNA 1620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.